Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation
Kuykendall, Andrew T., Shah, Savan, Talati, Chetasi, Al Ali, Najla, Sweet, Kendra, Padron, Eric, Sallman, David A., Lancet, Jeffrey E., List, Alan F., Zuckerman, Kenneth S., Komrokji, Rami S.Language:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-017-3194-4
Date:
November, 2017
File:
PDF, 505 KB
english, 2017